» Articles » PMID: 32912793

Common Cardiovascular Risk Factors and In-hospital Mortality in 3,894 Patients with COVID-19: Survival Analysis and Machine Learning-based Findings from the Multicentre Italian CORIST Study

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: There is poor knowledge on characteristics, comorbidities and laboratory measures associated with risk for adverse outcomes and in-hospital mortality in European Countries. We aimed at identifying baseline characteristics predisposing COVID-19 patients to in-hospital death.

Methods And Results: Retrospective observational study on 3894 patients with SARS-CoV-2 infection hospitalized from February 19th to May 23rd, 2020 and recruited in 30 clinical centres distributed throughout Italy. Machine learning (random forest)-based and Cox survival analysis. 61.7% of participants were men (median age 67 years), followed up for a median of 13 days. In-hospital mortality exhibited a geographical gradient, Northern Italian regions featuring more than twofold higher death rates as compared to Central/Southern areas (15.6% vs 6.4%, respectively). Machine learning analysis revealed that the most important features in death classification were impaired renal function, elevated C reactive protein and advanced age. These findings were confirmed by multivariable Cox survival analysis (hazard ratio (HR): 8.2; 95% confidence interval (CI) 4.6-14.7 for age ≥85 vs 18-44 y); HR = 4.7; 2.9-7.7 for estimated glomerular filtration rate levels <15 vs ≥ 90 mL/min/1.73 m; HR = 2.3; 1.5-3.6 for C-reactive protein levels ≥10 vs ≤ 3 mg/L). No relation was found with obesity, tobacco use, cardiovascular disease and related-comorbidities. The associations between these variables and mortality were substantially homogenous across all sub-groups analyses.

Conclusions: Impaired renal function, elevated C-reactive protein and advanced age were major predictors of in-hospital death in a large cohort of unselected patients with COVID-19, admitted to 30 different clinical centres all over Italy.

Citing Articles

Assessing the impact of vaccines on COVID-19 efficacy in survival rates: a survival analysis approach for clinical decision support.

Gonzalez Rodriguez J, Oprescu A, Munoz Lezcano S, Cordero Ramos J, Romero Cabrera J, Armengol de la Hoz M Front Public Health. 2024; 12:1437388.

PMID: 39624415 PMC: 11609198. DOI: 10.3389/fpubh.2024.1437388.


Surfactant-derived protein type B: a new biomarker linked to respiratory failure and lung damage in mild to moderate SARS-CoV-2 pneumonia.

Mapelli M, Salvioni E, Mattavelli I, Banfi C, Ghilardi S, Greco A ERJ Open Res. 2024; 10(6).

PMID: 39588076 PMC: 11587118. DOI: 10.1183/23120541.00301-2024.


Phenotype clustering of hospitalized high-risk patients with COVID-19 - a machine learning approach within the multicentre, multinational PCHF-COVICAV registry.

Sokolski M, Trenson S, Reszka K, Urban S, Sokolska J, Biering-Sorensen T Cardiol J. 2024; 31(4):512-521.

PMID: 38832553 PMC: 11374323. DOI: 10.5603/cj.98489.


The predictive power of data: machine learning analysis for Covid-19 mortality based on personal, clinical, preclinical, and laboratory variables in a case-control study.

Seyedtabib M, Najafi-Vosough R, Kamyari N BMC Infect Dis. 2024; 24(1):411.

PMID: 38637727 PMC: 11025285. DOI: 10.1186/s12879-024-09298-w.


Factors associated with the worsening of COVID-19 symptoms among cohorts in community- or home-isolation care in southern Thailand.

Sila T, Suriyaamorn W, Toh C, Rajborirug S, Surasombatpattana S, Thongsuksai P Front Public Health. 2024; 12:1350304.

PMID: 38572011 PMC: 10987961. DOI: 10.3389/fpubh.2024.1350304.


References
1.
Pelayo J, Lo K, Bhargav R, Gul F, Peterson E, DeJoy Iii R . Clinical Characteristics and Outcomes of Community- and Hospital-Acquired Acute Kidney Injury with COVID-19 in a US Inner City Hospital System. Cardiorenal Med. 2020; 10(4):223-231. PMC: 7360498. DOI: 10.1159/000509182. View

2.
Bonaccio M, Iacoviello L, Donati M, de Gaetano G . A Socioeconomic Paradox in the COVID-19 Pandemic in Italy: a Call to Study Determinants of Disease Severity in High and Low-Income Countries. Mediterr J Hematol Infect Dis. 2020; 12(1):e2020051. PMC: 7340247. DOI: 10.4084/MJHID.2020.051. View

3.
Colaneri M, Sacchi P, Zuccaro V, Biscarini S, Sachs M, Roda S . Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020. Euro Surveill. 2020; 25(16). PMC: 7189652. DOI: 10.2807/1560-7917.ES.2020.25.16.2000460. View

4.
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L . Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020; 97(5):829-838. PMC: 7110296. DOI: 10.1016/j.kint.2020.03.005. View

5.
Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M . Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension. Hypertension. 2020; 76(2):366-372. DOI: 10.1161/HYPERTENSIONAHA.120.15324. View